Inhibitory profiles of captopril on matrix metalloproteinase-9 activity.

[1]  K. Naka,et al.  Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. , 1992, The Journal of biological chemistry.

[2]  K. Fang,et al.  Dog Mast Cell α-Chymase Activates Progelatinase B by Cleaving the Phe88-Gln89 and Phe91-Glu92 Bonds of the Catalytic Domain* , 1997, The Journal of Biological Chemistry.

[3]  T. Ueno,et al.  Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. , 1998, Journal of the American College of Cardiology.

[4]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[5]  S. Takai,et al.  Beneficial effects of cardiac chymase inhibition during the acute phase of myocardial infarction. , 2002, Life sciences.

[6]  A. Henney,et al.  Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor. , 2002, Journal of molecular biology.

[7]  Richard T. Lee,et al.  Selective Matrix Metalloproteinase Inhibition Reduces Left Ventricular Remodeling but Does Not Inhibit Angiogenesis After Myocardial Infarction , 2002, Circulation.

[8]  Ook Joon Yoo,et al.  Crystal structure of Drosophila angiotensin I‐converting enzyme bound to captopril and lisinopril 1 , 2003, FEBS letters.

[9]  H. R. Evans,et al.  Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. , 2004, Biochemistry.

[10]  Richard T. Lee,et al.  Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. , 2006, American journal of physiology. Heart and circulatory physiology.

[11]  M. Pfeffer,et al.  Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system , 2007, Journal of hypertension.

[12]  S. Takai,et al.  The Significance of Chymase in the Progression of Abdominal Aortic Aneurysms in Dogs , 2007, Hypertension Research.

[13]  S. Takai,et al.  Molecular mechanism of imidapril for cardiovascular protection via inhibition of MMP-9. , 2007, Journal of molecular and cellular cardiology.

[14]  S. Takai,et al.  Prediction of interaction mode between a typical ACE inhibitor and MMP-9 active site. , 2007, Biochemical and biophysical research communications.

[15]  S. Takai,et al.  Inhibition of matrix metalloproteinase-9 activity by lisinopril after myocardial infarction in hamsters. , 2007, European journal of pharmacology.

[16]  M. Lindsey,et al.  ACE inhibitors to block MMP-9 activity: new functions for old inhibitors. , 2007, Journal of molecular and cellular cardiology.